Sino Biological introduces AI-trusted and qualified target protein collections for AI-driven discovery

As AI accelerates recombinant protein and antibody discovery for therapeutic and diagnostic development, access to well-characterized target proteins is essential for evaluating AI-designed molecules. Sino Biological, Inc., a global biotechnology company specializing in recombinant proteins, antibodies, and CRO services, introduces two dedicated target protein collections for AI-driven discovery: AI-trusted proteins and AI-qualified proteins.

Image Credit: Sino Biological Inc.

Together, these collections offer researchers access to target proteins with demonstrated use in AI research, experimentally characterized binding activity, and specialized formats to support diverse AI-driven validation.

Two collections. Two ways to support AI validation.

AI-trusted proteins – Proven in AI research

AI-Trusted Proteins have been used in AI-focused company validation projects, with some proteins featured in published research. This collection currently covers 600+ targets and 960+ individual proteins, with available characterization data for each protein potentially including SPR, BLI, ELISA, cell-based activity assays, SEC-HPLC, and SEC-MALS analyzes.

AI-qualified proteins – Characterized for AI validation

AI-qualified proteins feature experimentally characterized target binding activity, including SPR/BLI validation data, as well as specialized formats such as biotinylated proteins for AI-driven research. With 680+ targets and 1,700+ individual proteins, this collection provides researchers with a broad selection of characterized target proteins for evaluating AI-designed molecules.

The 4S system: Building confidence in target protein resources

Supporting these collections is Sino Biological's 4S System – scale, scope, speed, and supply, designed to provide the resource breadth, production capabilities, and supply reliability required by AI-driven discovery.

  • Scale: More than 11,000 recombinant target proteins, including over 1,200 biotinylated proteins.
  • Scope: Broad coverage of membrane, extracellular, and intracellular proteins, as well as mutants and diverse protein formats.
  • Speed: Rapid, scalable production, efficient order processing, and local inventory and delivery capabilities.
  • Supply: Lot-to-lot consistency, multi-lot availability, and reliable long-term supply.

Together, the 4S system helps researchers access a broad range of target proteins while supporting consistent experimental needs and ongoing AI research programs.

Sino Biological has also developed a therapeutic target directory covering 12 therapeutic areas and more than 100 diseases, enabling researchers to explore relevant targets by therapeutic area or disease.

4RISE™: Connecting target resources with end-to-end AI validation

Target proteins are a critical part of experimental validation. As a key resource within Sino Biological's 4RISE™ AI Lab Validation Solution, the AI-focused target protein library works alongside high-throughput protein expression, binding and affinity characterization, developability assessment, and functional validation.

Built around four strengths – Rapid, In-Depth, Seamless, and Empirical – 4RISE™ provides integrated wet-lab support to help researchers advance AI-designed molecules from computational predictions to experimental evidence.

AI-driven discovery depends on reliable experimental resources to evaluate designed molecules and guide subsequent research decisions, By combining AI-trusted and AI-qualified target proteins with our 4S System, we aim to provide researchers with well-characterized target resources, broad coverage, and dependable supply to support AI-driven protein and antibody discovery."

Dr. Rob Burgess, Chief Business Officer, Sino Biological US

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sino Biological Inc.. (2026, November 19). Sino Biological introduces AI-trusted and qualified target protein collections for AI-driven discovery. News-Medical. Retrieved on November 20, 2026 from https://www.news-medical.net/news/20261119/Sino-Biological-introduces-AI-trusted-and-qualified-target-protein-collections-for-AI-driven-discovery.aspx.

  • MLA

    Sino Biological Inc.. "Sino Biological introduces AI-trusted and qualified target protein collections for AI-driven discovery". News-Medical. 20 November 2026. <https://www.news-medical.net/news/20261119/Sino-Biological-introduces-AI-trusted-and-qualified-target-protein-collections-for-AI-driven-discovery.aspx>.

  • Chicago

    Sino Biological Inc.. "Sino Biological introduces AI-trusted and qualified target protein collections for AI-driven discovery". News-Medical. https://www.news-medical.net/news/20261119/Sino-Biological-introduces-AI-trusted-and-qualified-target-protein-collections-for-AI-driven-discovery.aspx. (accessed November 20, 2026).

  • Harvard

    Sino Biological Inc.. 2026. Sino Biological introduces AI-trusted and qualified target protein collections for AI-driven discovery. News-Medical, viewed 20 November 2026, https://www.news-medical.net/news/20261119/Sino-Biological-introduces-AI-trusted-and-qualified-target-protein-collections-for-AI-driven-discovery.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sino Biological launches XPressMAX™ Cell-Free Protein Synthesis Kit, accelerating AI-powered high-throughput antibody drug discovery